Philips: favorable results for tests on recalled respirators

0


(AOF) – Philips reported favorable results for tests carried out on certain sleep apnea treatment devices, which it recalled earlier this year. There was a risk that their foam would break down into particles, enter the air circuit and be inhaled by the user. The foam could also give off certain chemical gases.

Testing for first-generation DreamStation products has shown that exposure to “volatile organic compounds (VOCs)” (…) “is generally not expected to have long-term health consequences for patients.”

“This new assessment is limited to the assessment of VOCs for the first generation DreamStation devices. It does not assess the risks related to potential foam particles and does not cover other devices affected by the recall” stressed the group of electronics specializing in health and “Personal Care” products.

Full particle testing and analysis is expected to be completed in the second quarter of 2022.

© AOF

The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights owned by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial or non-commercial exploitation, creation of hypertext link or reuse in any way whatsoever of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from sources it considers the most reliable. However, subject to gross negligence, OPTION FINANCES SAS and its contributors in no way guarantee the absence of errors and defects, even hidden, nor the exhaustive nature or lack of conformity for any use whatsoever of these data and of OPTION FINANCE. SAS or one of its contributors, and cannot be held responsible for delays or interruptions that could affect access to them. The user of the OPTION FINANCE SAS service will use AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.





Source link -92